Danhier F - Search Results

1

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles.

Danhier F, Pourcelle V, Marchand-Brynaert J, Jérôme C, Feron O, Préat V. Danhier F, et al. Methods Enzymol. 2012;508:157-75. doi: 10.1016/B978-0-12-391860-4.00008-2. Methods Enzymol. 2012. PMID: 22449925

2

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Danhier F, et al. J Control Release. 2009 Jan 5;133(1):11-7. doi: 10.1016/j.jconrel.2008.09.086. Epub 2008 Oct 9. J Control Release. 2009. PMID: 18950666

3

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel.

Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Danhier F, et al. J Control Release. 2009 Dec 3;140(2):166-73. doi: 10.1016/j.jconrel.2009.08.011. Epub 2009 Aug 20. J Control Release. 2009. PMID: 19699245

4

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.

Danhier F, Feron O, Préat V. Danhier F, et al. J Control Release. 2010 Dec 1;148(2):135-46. doi: 10.1016/j.jconrel.2010.08.027. Epub 2010 Aug 24. J Control Release. 2010. PMID: 20797419 Review.

5

Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.

Schleich N, Sibret P, Danhier P, Ucakar B, Laurent S, Muller RN, Jérôme C, Gallez B, Préat V, Danhier F. Schleich N, et al. Among authors: danhier p, danhier f. Int J Pharm. 2013 Apr 15;447(1-2):94-101. doi: 10.1016/j.ijpharm.2013.02.042. Epub 2013 Feb 26. Int J Pharm. 2013. PMID: 23485340

6

Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.

Bastiancich C, Danhier P, Préat V, Danhier F. Bastiancich C, et al. Among authors: danhier p, danhier f. J Control Release. 2016 Dec 10;243:29-42. doi: 10.1016/j.jconrel.2016.09.034. Epub 2016 Sep 28. J Control Release. 2016. PMID: 27693428 Review.

7

Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621.

Danhier F, Ucakar B, Magotteaux N, Brewster ME, Préat V. Danhier F, et al. Int J Pharm. 2010 Jun 15;392(1-2):20-8. doi: 10.1016/j.ijpharm.2010.03.018. Epub 2010 Mar 11. Int J Pharm. 2010. PMID: 20226846

8

PLGA-based nanoparticles: an overview of biomedical applications.

Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. Danhier F, et al. J Control Release. 2012 Jul 20;161(2):505-22. doi: 10.1016/j.jconrel.2012.01.043. Epub 2012 Feb 4. J Control Release. 2012. PMID: 22353619 Review.

9

RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.

Danhier F, Le Breton A, Préat V. Danhier F, et al. Mol Pharm. 2012 Nov 5;9(11):2961-73. doi: 10.1021/mp3002733. Epub 2012 Oct 4. Mol Pharm. 2012. PMID: 22967287 Review.

10

Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.

Duhem N, Danhier F, Pourcelle V, Schumers JM, Bertrand O, Leduff CS, Hoeppener S, Schubert US, Gohy JF, Marchand-Brynaert J, Préat V. Duhem N, et al. Among authors: danhier f. Bioconjug Chem. 2014 Jan 15;25(1):72-81. doi: 10.1021/bc400326y. Epub 2013 Dec 23. Bioconjug Chem. 2014. PMID: 24328289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters